ADC Therapeutics Secures $86.6 Million PIPE to Extend Cash Runway into 2029
ADC Therapeutics (ADCT) secures an $86.6 million private placement to fund ZYNLONTA Phase 3 clinical trials and extend its cash runway into the year 2029.
Capital Raise
Stock offerings, convertible notes, debt raises and private placements.
Crescent Energy Prices $1.15 Billion Stock Offering for Eagle Ford Asset Acquisition
Atrium Therapeutics Shares Rise 5% in 1 Day Since Raising $50M in PIPE Offering
WhiteHawk Minerals Corp. Launches $100 Million Series F Preferred Stock Offering
HighPeak Energy Shares Skyrocket 30% in 5 Days Since Securing $450 Million in Preferred Equity
Capital Raise
Flex Ltd. Secures $2 Billion Preferred Investment for Axiom Subsidiary Spin-Off
Flex Ltd. enters agreement for a $2.0 billion convertible preferred investment in its Axiom subsidiary to fund the EPC Power acquisition and 2027 spin-off.
Capital Raise
Surrozen Secures $95.1 Million Capital Infusion Following FDA Clearance for SZN-8141
Surrozen (SRZN) to receive $95.1 million in gross proceeds following FDA clearance of the SZN-8141 IND, triggering the second closing of a private placement.
Capital Raise
Accelevation Holdings Corp. Prices $540 Million Initial Public Offering at $18 Per Share
Accelevation Holdings Corp. (ACCV) closes $540 million IPO, offering 30 million shares at $18.00. The industrial company lists on the Nasdaq under ticker ACCV.
